Keros Therapeutics, Inc. · NASDAQ:KROS

ExodusPoint Capital Management, LP's stake in Keros Therapeutics, Inc. fell to 0.04% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

ExodusPoint Capital Management, LP's stake in Keros Therapeutics, Inc. fell to 0.04%, 13,360 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
0.04%
Shares
13,360
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
ExodusPoint Capital Management, LP0.04%13,360
ExodusPoint Capital Partners GP, LLC0.04%13,360
Michael Gelband0.04%13,360

Source

View original at SEC

Related